Krystal Biotech, Inc. (KRYS)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$345.82+$0.8600 (+0.25%) on the dayAs of the close; data may be delayed.
KRYS price, last 12 months
Key stats
- Previous close
- $344.96
- Open
- $346.34
- Day range
- $341.90 – $347.74
- 52-week range
- $158.08 – $382.54
- Volume
- 159.9K
- Avg volume (20 days)
- 270.7K
- Market cap
- $10.2B
Performance
1W+2.7%
1M−3.9%
3M−7.1%
6M+37.6%
YTD+40.3%
1Y+113.5%
vs S&P 500, 1Y+96.7 pts
Technicals and fundamentals
About Krystal Biotech, Inc.
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $10.2B